share_log

Mizuho Maintains Buy on CVS Health, Lowers Price Target to $72

Benzinga ·  May 2 07:45

Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $86 to $72.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment